Mutation of FOXL2 in granulosa-cell tumors of the ovary.

BACKGROUND Granulosa-cell tumors (GCTs) are the most common type of malignant ovarian sex cord-stromal tumor (SCST). The pathogenesis of these tumors is unknown. Moreover, their histopathological diagnosis can be challenging, and there is no curative treatment beyond surgery. METHODS We analyzed four adult-type GCTs using whole-transcriptome paired-end RNA sequencing. We identified putative GCT-specific mutations that were present in at least three of these samples but were absent from the transcriptomes of 11 epithelial ovarian tumors, published human genomes, and databases of single-nucleotide polymorphisms. We confirmed these variants by direct sequencing of complementary DNA and genomic DNA. We then analyzed additional tumors and matched normal genomic DNA, using a combination of direct sequencing, analyses of restriction-fragment-length polymorphisms, and TaqMan assays. RESULTS All four index GCTs had a missense point mutation, 402C-->G (C134W), in FOXL2, a gene encoding a transcription factor known to be critical for granulosa-cell development. The FOXL2 mutation was present in 86 of 89 additional adult-type GCTs (97%), in 3 of 14 thecomas (21%), and in 1 of 10 juvenile-type GCTs (10%). The mutation was absent in 49 SCSTs of other types and in 329 unrelated ovarian or breast tumors. CONCLUSIONS Whole-transcriptome sequencing of four GCTs identified a single, recurrent somatic mutation (402C-->G) in FOXL2 that was present in almost all morphologically identified adult-type GCTs. Mutant FOXL2 is a potential driver in the pathogenesis of adult-type GCTs.

[1]  J. Fletcher,et al.  Ovarian granulosa-stromal cell tumors are characterized by trisomy 12. , 1991, The American journal of pathology.

[2]  T. Löning,et al.  p53 mutations in ovarian tumors, detected by temperature‐gradient gel electrophoresis, direct sequencing and immunohistochemistry , 1995, International journal of cancer.

[3]  L. Twiggs,et al.  Mitotic count, nuclear atypia, and immunohistochemical determination of Ki-67, c-myc, p21-ras, c-erbB2, and p53 expression in granulosa cell tumors of the ovary: mitotic count and Ki-67 are indicators of poor prognosis. , 1996, Gynecologic oncology.

[4]  Fu‐shing Liu,et al.  Overexpression of p53 is not a feature of ovarian granulosa cell tumors. , 1996, Gynecologic oncology.

[5]  H. Brunner,et al.  Analysis of mutations in genes of the follicle-stimulating hormone receptor signaling pathway in ovarian granulosa cell tumors. , 1999, The Journal of clinical endocrinology and metabolism.

[6]  K. Devriendt,et al.  Spectrum of FOXL2 gene mutations in blepharophimosis-ptosis-epicanthus inversus (BPES) families demonstrates a genotype--phenotype correlation. , 2001, Human molecular genetics.

[7]  D. Schlessinger,et al.  The putative forkhead transcription factor FOXL2 is mutated in blepharophimosis/ptosis/epicanthus inversus syndrome , 2001, Nature Genetics.

[8]  R. Veitia,et al.  Evolution and expression of FOXL2 , 2002, Journal of medical genetics.

[9]  S. Cannistra,et al.  Granulosa cell tumor of the ovary. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[10]  B. Ellsworth,et al.  The gonadotropin releasing hormone (GnRH) receptor activating sequence (GRAS) is a composite regulatory element that interacts with multiple classes of transcription factors including Smads, AP-1 and a forkhead DNA binding protein , 2003, Molecular and Cellular Endocrinology.

[11]  J. Vandesompele,et al.  The human FOXL2 mutation database , 2004, Human mutation.

[12]  S. Chu,et al.  Signalling pathways in the molecular pathogenesis of ovarian granulosa cell tumours , 2004, Trends in Endocrinology & Metabolism.

[13]  G. Crooks,et al.  WebLogo: a sequence logo generator. , 2004, Genome research.

[14]  Katrin Anlag,et al.  The murine winged-helix transcription factor Foxl2 is required for granulosa cell differentiation and ovary maintenance , 2004, Development.

[15]  M. Pisarska,et al.  Forkhead l2 is expressed in the ovary and represses the promoter activity of the steroidogenic acute regulatory gene. , 2004, Endocrinology.

[16]  G. Churchill,et al.  Distal Chr 4 harbors a genetic locus (Gct1) fundamental for spontaneous ovarian granulosa cell tumorigenesis in a mouse model. , 2005, Cancer research.

[17]  Mario Cazzola,et al.  A gain-of-function mutation of JAK2 in myeloproliferative disorders. , 2005, The New England journal of medicine.

[18]  R. Young,et al.  Sex cord-stromal tumors of the ovary and testis: their similarities and differences with consideration of selected problems , 2005, Modern Pathology.

[19]  R. Veitia,et al.  FOXL2 activates P450 aromatase gene transcription: towards a better characterization of the early steps of mammalian ovarian development. , 2006, Journal of molecular endocrinology.

[20]  N. Colombo,et al.  Management of ovarian stromal cell tumors. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[21]  J. Diebold,et al.  Analysis of selected oncogenes (AKT1, FOS, BCL2L2, TGFbeta) on chromosome 14 in granulosa cell tumors (GCTs): a comprehensive study on 30 GCTs combining comparative genomic hybridization (CGH) and fluorescence-in situ-hybridization (FISH). , 2008, Pathology, research and practice.

[22]  Ryan D. Morin,et al.  Profiling the HeLa S3 transcriptome using randomly primed cDNA and massively parallel short-read sequencing. , 2008, BioTechniques.

[23]  D. Busam,et al.  An Integrated Genomic Analysis of Human Glioblastoma Multiforme , 2008, Science.

[24]  G. Parmigiani,et al.  Integrated analysis of homozygous deletions, focal amplifications, and sequence alterations in breast and colorectal cancers , 2008, Proceedings of the National Academy of Sciences.

[25]  Kylie L. Gorringe,et al.  No evidence of clonal somatic genetic alterations in cancer-associated fibroblasts from human breast and ovarian carcinomas , 2008, Nature Genetics.

[26]  Antony V. Cox,et al.  Identification of somatically acquired rearrangements in cancer using genome-wide massively parallel paired-end sequencing , 2008, Nature Genetics.

[27]  R. Durbin,et al.  Mapping Quality Scores Mapping Short Dna Sequencing Reads and Calling Variants Using P

, 2022 .

[28]  Amy E. Hawkins,et al.  DNA sequencing of a cytogenetically normal acute myeloid leukemia genome , 2008, Nature.

[29]  Chengquan Zhao,et al.  Identification of the Most Sensitive and Robust Immunohistochemical Markers in Different Categories of Ovarian Sex Cord-stromal Tumors , 2009, The American journal of surgical pathology.

[30]  M. Stratton,et al.  The cancer genome , 2009, Nature.